Literature DB >> 9494698

Depression in schizophrenia: II. MRI and PET findings.

C Kohler1, C L Swanson, R C Gur, L H Mozley, R E Gur.   

Abstract

BACKGROUND: Despite consistent descriptions of depressive symptoms in schizophrenia, little is known about their neurobiology. The purpose of this study was to examine the association of depression in schizophrenia with measures of brain anatomy and metabolism.
METHODS: Seventy-nine patients were grouped according to their ratings on the Hamilton Depression Rating Scale (HDRS): > or = 18 was the cutoff between the "high" and "low" depression groups. All patients underwent clinical and magnetic resonance imaging (MRI) evaluation, and a subsample of 37 underwent 2-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET) measurements of cerebral glucose metabolism.
RESULTS: The high depression group had larger bilateral temporal lobe volumes and decreased laterality (left minus right of metabolism in the anterior cingulate).
CONCLUSIONS: The neurobiology of depression in schizophrenia thus seems to share features with major depression due to other disease states.

Entities:  

Mesh:

Year:  1998        PMID: 9494698     DOI: 10.1016/S0006-3223(97)00298-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  5 in total

1.  Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis.

Authors:  David C Glahn; Angela R Laird; Ian Ellison-Wright; Sarah M Thelen; Jennifer L Robinson; Jack L Lancaster; Edward Bullmore; Peter T Fox
Journal:  Biol Psychiatry       Date:  2008-05-16       Impact factor: 13.382

2.  Mapping Depression in Schizophrenia: A Functional Magnetic Resonance Imaging Study.

Authors:  Veena Kumari; Emmanuelle Peters; Ashley Guinn; Dominic Fannon; Tamara Russell; Alexander Sumich; Elizabeth Kuipers; Steven C R Williams; Dominic H Ffytche
Journal:  Schizophr Bull       Date:  2015-12-27       Impact factor: 9.306

3.  Structural abnormalities of cingulate cortex in patients with first-episode drug-naïve schizophrenia comorbid with depressive symptoms.

Authors:  Gao-Xia Wei; Likun Ge; Li-Zhen Chen; Bo Cao; Xiangyang Zhang
Journal:  Hum Brain Mapp       Date:  2020-12-09       Impact factor: 5.038

4.  Exploring the link between cognitive deficit, self-esteem, alexithymia, and depressive symptom of schizophrenia.

Authors:  Chen He; Xueying Zhang; Qingrong Xia; Hua Gao; Junwei Yan; Xuequan Chen; Hui Yuan; Yang Zhang; Wen Xie; Cuizhen Zhu
Journal:  Brain Behav       Date:  2022-06-08       Impact factor: 3.405

5.  Associations between depressive symptoms and fronto-temporal activities during a verbal fluency task in patients with schizophrenia.

Authors:  Shenghong Pu; Kazuyuki Nakagome; Akihiko Miura; Masaaki Iwata; Izumi Nagata; Koichi Kaneko
Journal:  Sci Rep       Date:  2016-07-28       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.